2m 2m 2m 2m 2m 2m 2m
Teladoc Health (TDOC)
NYSE
$7.66-$0.03 (-0.38%)
Price as of Jun 23, 2026 7:08 PM EDT- $1.4BMarket Cap
- -3.93%1-Year Change
- Health Information ServicesIndustry
Teladoc Health (TDOC)
$7.66-$0.03 (-0.38%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.5B -1.54% | 2.6B -1.26% | 2.6B +8.13% | 2.4B +18.41% | |
Cost of Revenue | 771.6M +2.71% | 751.3M -1.15% | 760.0M +2.16% | 744.0M +14.41% | |
Gross Profit | 1.8B -3.30% | 1.8B -1.31% | 1.8B +10.80% | 1.7B +20.28% | |
Sales and Marketing Expense | 653.4M -7.43% | 705.8M +2.46% | 688.9M +10.48% | 623.5M +49.63% | |
Research and Development Expense | -277.9M -9.55% | -307.3M -11.83% | -348.5M -204.46% | 333.6M +6.97% | |
Depreciation and Amortization Expense | 30.7M -91.55% | 363.4M +11.48% | 325.9M +27.30% | 256.0M +25.36% | |
Total Operating Expenses | 2.8B -22.21% | 3.6B +25.94% | 2.9B -82.25% | 16.1B +598.77% | |
Operating Profit | -263.0M -74.24% | -1.0B +310.73% | -248.6M -98.18% | -13.7B +5,039.92% | |
Interest Income | 36.8M -35.57% | 57.1M +21.99% | 46.8M N/A | N/A N/A | |
Interest Expense | -4,000 -99.98% | -23.8M +6.83% | -22.3M +140.37% | -9.3M -88.47% | |
Interest Income and Expense and Net | 36.8M +10.51% | 33.3M +35.79% | 24.5M +364.29% | -9.3M -88.47% | |
Total Nonoperating Income and Expense | 10.4M +271.81% | -6.0M -235.77% | 4.4M +617.46% | -859,000 -116.88% | |
Income before Taxes | -235.5M -76.30% | -993.7M +352.47% | -219.6M -98.39% | -13.7B +3,452.09% | |
Income Taxes | -35.2M -563.75% | 7.6M +898.95% | 760,000 +119.94% | -3.8M -108.64% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -200.3M -79.99% | -1.0B +354.35% | -220.4M -98.39% | -13.7B +3,085.58% | |
Net Income from Continuing Operations Applicable to Common | -235.5M -76.30% | -993.7M +352.47% | -219.6M -98.39% | -13.7B +3,452.09% | |
Basic EPS and Net Income | -1.14 -80.58% | -5.87 +338.06% | -1.34 -98.42% | -84.60 +2,998.90% | |
Diluted EPS and Net Income | -1.14 -80.58% | -5.87 +338.06% | -1.34 -98.42% | -84.60 +2,998.90% | |
Basic Weighted Average Shares | 176.2M +3.32% | 170.6M +3.64% | 164.6M +1.93% | 161.5M +2.88% | |
Diluted Weighted Average Shares | 176.2M +3.32% | 170.6M +3.64% | 164.6M +1.93% | 161.5M +2.88% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 781.1M -39.84% | 1.3B +15.54% | 1.1B +22.38% | 918.2M +2.76% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Cash and Cash Equivalents and Short-Term Investments | 781.1M -39.84% | 1.3B +15.54% | 1.1B +22.38% | 918.2M +2.47% | |
Total Current Assets | 1.1B -32.74% | 1.7B +11.74% | 1.5B +13.20% | 1.3B +7.34% | |
Accumulated Depreciation | 85.2M +19.44% | 71.4M +19.45% | 59.7M +25.21% | 47.7M +39.79% | |
Property and Plant and Equipment and Net | 27.0M -8.53% | 29.5M -7.95% | 32.0M +8.07% | 29.6M +8.84% | |
Total Long-Term Assets | 105.8M +29.84% | 81.5M +1.53% | 80.3M +65.34% | 48.5M +134.46% | |
Total Assets | 2.9B -18.72% | 3.5B -19.94% | 4.4B +1.08% | 4.3B -75.50% | |
Income Taxes Payable | 28.9M -41.94% | 49.9M +0.81% | 49.5M -2.92% | 50.9M -32.78% | |
Total Short-Term Debt | 0 -100.00% | 550.7M N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 404.7M -57.01% | 941.5M +123.85% | 420.6M +5.21% | 399.8M +20.77% | |
Total Long-Term Debt | 994.9M +0.35% | 991.4M -35.57% | 1.5B +0.22% | 1.5B +25.26% | |
Total Long-Term Liabilities | 643,000 -10.69% | 720,000 -33.33% | 1.1M -33.25% | 1.6M +8.45% | |
Total Liabilities | 1.5B -27.30% | 2.0B +337.03% | 463.5M +5.86% | 437.8M +17.44% | |
Retained Earnings | -16.4B +1.23% | -16.2B +6.57% | -15.2B +1.47% | -15.0B +955.84% | |
Total Stockholders Equity | 1.4B -7.07% | 1.5B -35.90% | 2.3B +0.79% | 2.3B -85.62% | |
Total Shares Outstanding | 178.3M +2.83% | 173.4M +4.05% | 166.7M +2.34% | 162.8M +1.48% | |
Cash Flow | |||||
Cash from Operating Activities | 294.4M +0.23% | 293.7M -16.10% | 350.0M +84.91% | 189.3M -2.42% | |
Capital Expenditures | 8.9M -17.58% | 10.8M -5.88% | 11.5M -30.44% | 16.5M +93.11% | |
Cash from Investing Activities | -266.0M +114.43% | -124.1M -20.66% | -156.3M -6.79% | -167.7M +129.84% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -551.7M -6,736.81% | 8.3M -23.42% | 10.9M +67.06% | 6.5M -84.13% | |
Financials Ratio | |||||
Gross Margin | 69.50% -1.78% | 70.76% -0.05% | 70.80% +2.47% | 69.09% +1.59% | |
Operating Margin | -10.39% -73.84% | -39.73% +315.98% | -9.55% -98.32% | -567.27% +4,240.95% | |
Return on Assets | -6.28% -75.18% | -25.32% +401.96% | -5.04% -95.92% | -123.73% +5,020.34% | |
Return on Equity | -13.93% -73.45% | -52.46% +451.56% | -9.51% -93.61% | -148.85% +5,441.88% | |
Revenue Growth | -1.54% +22.12% | -1.26% -115.53% | 8.13% -55.85% | 18.41% -78.55% | |
Current Ratio | 2.77 +56.47% | 1.77 -50.08% | 3.54 +7.59% | 3.29 -11.12% | |
Cash Ratio | 1.93 +39.96% | 1.38 -48.38% | 2.67 +16.31% | 2.30 -14.91% | |
Debt-to-Equity Ratio | 0.72 -30.57% | 1.03 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.35 -20.62% | 0.44 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow